-
Latest News
- Rethinking ME: a report by the All-Party Parliamentary Group on Myalgic Encephalomyelitis
- BCUHB plan to improve ME/CFS services in north Wales
- Aneurin Bevan Health Board plans ME/CFS pathway
- NICE outlines steps needed to put ME/CFS guideline into practice
- Share #LearnFromME quotes on #WorldMEday 2022
Archives
Tag Archives: Nina Groven
MCP-1 is increased in patients with CFS & FM, whilst several other immune markers are significantly lower than healthy controls
MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls, by Nina Groven, Egil Andreas Fors, Astrid Kamilla Stunes, Solveig Klæbo Reitan in Brain, Behavior, & Immunity – Health Vol … Continue reading
Posted in News
Tagged Astrid Kamilla Stunes, CCL2, chemokines, cytokines, Egil Andreas Fors, IL-10, IL-1β, Il-4, IL-6, IL17, inflammation, interferon gamma, interleukins, MCP-1, Monocyte Chemoattractant Protein, Nina Groven, Solveig Klæbo Reitan, TGF-β1, TGF-β2, TGF-β3, TNF-α
Comments Off on MCP-1 is increased in patients with CFS & FM, whilst several other immune markers are significantly lower than healthy controls
Patients with FM & CFS show increased hsCRP compared to healthy controls
Patients with Fibromyalgia and Chronic Fatigue Syndrome show increased hsCRP compared to healthy controls, by Nina Groven, Egil A Fors, Solveig KlæboReitan, in Brain, Behavior, and Immunity [Available online 7 June 2019] https://doi.org/10.1016/j.bbi.2019.06.010 Highlights CFS/ME and Fibromyalgia share common features of … Continue reading
Posted in News
Tagged C-reactive protein, CRP, Egil A Fors, Fibromyalgia, FMS, hsCRP, inflammatory biomarkers, Nina Groven, Solveig Klæbo Reitan
Comments Off on Patients with FM & CFS show increased hsCRP compared to healthy controls